Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective

被引：0
|
作者：
Jean-Louis Vincent
Rolf Rossaint
Bruno Riou
Yves Ozier
David Zideman
Donat R Spahn
机构：
[1] Erasme Hospital,Department of Intensive Care
[2] Free University of Brussels,Department of Anaesthesiology of the University Hospital
[3] RWTH,Department of Emergency Medicine and Surgery and Department of Anesthesiology and Critical Care
[4] Hôpital Pitié-Salpêtrière,Department of Anaesthesiology
[5] Assistance Publique-Hôpitaux de Paris,undefined
[6] Université Pierre et Marie Curie,undefined
[7] Service d'Anesthésie-Réanimation Chirurgicale,undefined
[8] Hôpital Cochin,undefined
[9] Assistance publique-Hôpitaux de Paris,undefined
[10] Faculté de Medecine,undefined
[11] Paris-V,undefined
[12] Université Rene-Descartes,undefined
[13] European Resuscitation Council,undefined
[14] ERC Secretariat,undefined
[15] University Hospital Lausanne,undefined
来源：
Critical Care | / 10卷
关键词：
Orthotopic Liver Transplantation; Blunt Trauma; Fresh Freeze Plasma; Recombinant Factor VIIa; rFVIIa Administration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Use of recombinant activated factor VII in patients with severe coagulopathy and bleeding - In Reply
    Svartholm, E
    Annerhagen, V
    Lanne, T
    ANESTHESIOLOGY, 2003, 98 (04) : 1027 - 1027
  • [32] Use of Recombinant Activated Factor VII to Arrest Uncontrolled Bleeding: A Case Series
    Alsayegh, Faisal
    Fakeir, Aisha
    Alhumood, Salah
    Abdumalek, Kafaya
    Matar, Hatem
    Samaul, Isaac
    Nampoory, Narayanan
    Kabalawi, Housam
    Mousa, Shaker A.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2009, 15 (02) : 225 - 232
  • [33] Evidence supporting the use of recombinant activated factor VII in congenital bleeding disorders
    Johansson, Par I.
    Ostrowski, Sisse R.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2010, 4 : 107 - 116
  • [34] Benefits and risks of recombinant activated factor VII (rFVIIa) in massive bleeding: a single centre study
    Panizo, E.
    Lecumberri, R.
    Rodriguez-Otero, P.
    Hernandez, M.
    Pegenaute, C.
    Paramo, J. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1160 - 1160
  • [35] Efficacy of recombinant activated Factor VII in patients with massive uncontrolled bleeding: a retrospective observational analysis
    Berkhof, Farida F.
    Eikenboom, Jeroen C. J.
    TRANSFUSION, 2009, 49 (03) : 570 - 577
  • [36] Recombinant activated factor VII for the treatment of bleeding in abdominal surgery and cardiac surgery
    G Michalska
    R Stanek
    Critical Care, 13 (Suppl 1):
  • [37] Treatment of massive gastrointestinal bleeding occurred during autologous stem cell transplantation with recombinant activated factor VII and octreotide
    Atas, Erman
    Kesik, Vural
    Gursel, Orhan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (03) : 667
  • [38] Successful treatment of massive acute lower gastrointestinal bleeding in diverticular disease of colon, with activated recombinant factor VII (NovoSeven)
    Ali, Zahida S.
    Al-Shaalan, Haydar
    Jorgensen, Jorgen
    BLOOD COAGULATION & FIBRINOLYSIS, 2006, 17 (04) : 327 - 329
  • [39] Recombinant activated factor VII (rFVIIa) for the treatment of bleeding secondary to acquired factor VIII inhibitor
    Baudo, F
    Gaidano, G
    Carloni, MT
    Coppola, A
    Fariciotti, A
    Iorio, A
    Marietta, M
    Marongiu, F
    Mazzucconi, MG
    Miraglia, E
    Schiavoni, M
    Schinco, PC
    BLOOD, 2002, 100 (11) : 100B - 100B
  • [40] Recombinant activated factor VII for adjunctive hemorrhage control in trauma - Discussion
    Holcomb, J
    Mattox, KL
    Schreiber, MA
    Martinowitz, U
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2001, 51 (03): : 438 - 439
12345